These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16823607)

  • 1. The probability of treatment induced drug resistance.
    Schinazi RB
    Acta Biotheor; 2006; 54(1):13-9. PubMed ID: 16823607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defeating pathogen drug resistance: guidance from evolutionary theory.
    Pepper JW
    Evolution; 2008 Dec; 62(12):3185-91. PubMed ID: 18803686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probability of resistance evolution for exponentially growing virus in the host.
    Haeno H; Iwasa Y
    J Theor Biol; 2007 May; 246(2):323-31. PubMed ID: 17306832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Within-host population dynamics of antibiotic-resistant M. tuberculosis.
    Alavez-Ramírez J; Castellanos JR; Esteva L; Flores JA; Fuentes-Allen JL; García-Ramos G; Gómez G; López-Estrada J
    Math Med Biol; 2007 Mar; 24(1):35-56. PubMed ID: 17060491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytic formulas for discrete stochastic models of cell populations with both differentiation and de-differentiation.
    Hotton S; Colvin ME
    J Theor Biol; 2007 Apr; 245(4):610-26. PubMed ID: 17196993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer.
    Komarova NL; Wodarz D
    Theor Popul Biol; 2007 Dec; 72(4):523-38. PubMed ID: 17915274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of antimicrobial use on emergence and selection of resistance].
    Harbarth S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):130-5. PubMed ID: 17309021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coselection for microbial resistance to metals and antibiotics in freshwater microcosms.
    Stepanauskas R; Glenn TC; Jagoe CH; Tuckfield RC; Lindell AH; King CJ; McArthur JV
    Environ Microbiol; 2006 Sep; 8(9):1510-4. PubMed ID: 16913911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of HIV-1 drug resistance during antiretroviral treatment.
    Rong L; Feng Z; Perelson AS
    Bull Math Biol; 2007 Aug; 69(6):2027-60. PubMed ID: 17450401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding cisplatin resistance using cellular models.
    Stordal B; Davey M
    IUBMB Life; 2007 Nov; 59(11):696-9. PubMed ID: 17885832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogen spectrum and drug resistance of spit samples from cancer patients].
    Wu XP; Zhang L; Tan XL; Liu XM; He LR
    Ai Zheng; 2007 Dec; 26(12):1336-8. PubMed ID: 18076796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD; Li M; Yuan Y; Mao N; Pan LY
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug induced superinfection in HIV and the evolution of drug resistance.
    Leontiev VV; Maury WJ; Hadany L
    Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century.
    Septimus EJ; Kuper KM
    Clin Pharmacol Ther; 2009 Sep; 86(3):336-9. PubMed ID: 19571803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens.
    Poulakou G; Kontopidou FV; Paramythiotou E; Kompoti M; Katsiari M; Mainas E; Nicolaou C; Yphantis D; Antoniadou A; Trikka-Graphakos E; Roussou Z; Clouva P; Maguina N; Kanellakopoulou K; Armaganidis A; Giamarellou H
    J Infect; 2009 Apr; 58(4):273-84. PubMed ID: 19344841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response.
    Deforche K; Cozzi-Lepri A; Theys K; Clotet B; Camacho RJ; Kjaer J; Van Laethem K; Phillips A; Moreau Y; Lundgren JD; Vandamme AM;
    Antivir Ther; 2008; 13(3):399-407. PubMed ID: 18572753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.